Erectile dysfunction (ED) is inconvenient enough on its own. The last thing you want is a pile-on of other inconveniences, like having to go to a doctor’s office for a diagnosis and prescription — and ...

Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...

Since my last update, Hims & Hers Health, Inc. stock has fallen by >25% before recovering all of its losses. Recent news flow has been mixed, with some insider selling and criticism of some business ...